Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation. | Front Immunol | 2023 | 37497215 | PubTator, text mining | PubMed |
| Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells. | Glycobiology | 2023 | 37486674 | PubTator, text mining | PubMed |
| Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. | Nat Commun | 2023 | 37474523 | PubTator, text mining | PubMed |
| Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis. | Exp Mol Med | 2023 | 37464092 | PubTator, text mining | PubMed |
| Vedolizumab for induction and maintenance of remission in Crohn's disease. | Cochrane Database Syst Rev | 2023 | 37458279 | PubTator, text mining | PubMed |
| Pediatric IBD patients show medication and disease activity dependent changes in NK cell and CD4 memory T cell populations. | Front Pediatr | 2023 | 37456566 | PubTator, text mining | PubMed |
| MAdCAM-1: a newly identified microbial 'gut check' for T cells. | Trends Immunol | 2023 | 37451906 | PubTator, text mining | PubMed |
| The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report. | Medicine (Baltimore) | 2023 | 37443475 | PubTator, text mining | PubMed |
| Genomic and evolutionary characteristics of metastatic gastric cancer by routes. | Br J Cancer | 2023 | 37422528 | PubTator, text mining | PubMed |
| Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance. | Oncoimmunology | 2023 | 37405191 | PubTator, text mining | PubMed |
| Case report: Induction and maintenance of steroid-free remission with vedolizumab in a case of steroid-dependent autoimmune pancreatitis. | Front Immunol | 2023 | 37404824 | PubTator, text mining | PubMed |
| An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management. | Front Immunol | 2023 | 37404814 | PubTator, text mining | PubMed |
| High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma. | Cell Prolif | 2023 | 37401015 | PubTator, text mining | PubMed |
| A clinically applicable molecular classification of oncocytic cell thyroid nodules. | Endocr Relat Cancer | 2023 | 37399519 | PubTator, text mining | PubMed |
| Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling. | Oncoimmunology | 2023 | 37396957 | PubTator, text mining | PubMed |
| Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease. | Ann Gastroenterol | 2023 | 37396005 | PubTator, text mining | PubMed |
| Immune-Modulating Lipid Nanomaterials for the Delivery of Biopharmaceuticals. | Pharmaceutics | 2023 | 37376208 | PubTator, text mining | PubMed |
| CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA. | Cell Biosci | 2023 | 37370191 | PubTator, text mining | PubMed |
| Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease. | Gut Microbes | 2023 | 37305973 | PubTator, text mining | PubMed |
| Autosomal recessive variants c.953A>C and c.97-1G>C in NSUN2 causing intellectual disability: a molecular dynamics simulation study of loss-of-function mechanisms. | Front Neurol | 2023 | 37305761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=9